111 related articles for article (PubMed ID: 20811685)
1. Possibility of paclitaxel as an alternative radiosensitizer to 5-fluorouracil for colon cancer.
Hiro J; Inoue Y; Toiyama Y; Yoshiyama S; Tanaka K; Mohri Y; Miki C; Kusunoki M
Oncol Rep; 2010 Oct; 24(4):1029-34. PubMed ID: 20811685
[TBL] [Abstract][Full Text] [Related]
2. Administration sequence-dependent antitumor effects of paclitaxel and 5-fluorouracil in the human gastric cancer cell line MKN45.
Toiyama Y; Tanaka K; Konishi N; Mohri Y; Tonouchi H; Miki C; Kusunoki M
Cancer Chemother Pharmacol; 2006 Feb; 57(3):368-75. PubMed ID: 16075279
[TBL] [Abstract][Full Text] [Related]
3. The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.
Ojima E; Inoue Y; Watanabe H; Hiro J; Toiyama Y; Miki C; Kusunoki M
Oncol Rep; 2006 Nov; 16(5):1085-91. PubMed ID: 17016597
[TBL] [Abstract][Full Text] [Related]
4. Combination of 5-fluorouracil and irinotecan on modulation of thymidylate synthase and topoisomerase I expression and cell cycle regulation in human colon cancer LoVo cells: clinical relevance.
Xu JM; Azzariti A; Tommasi S; Lacalamita R; Colucci G; Johnston PG; Church SW; Paradiso A
Clin Colorectal Cancer; 2002 Nov; 2(3):182-8. PubMed ID: 12482336
[TBL] [Abstract][Full Text] [Related]
5. Effect of pentoxifylline on radiation-induced G2-phase delay and radiosensitivity of human colon and cervical cancer cells.
Li YX; Weber-Johnson K; Sun LQ; Paschoud N; Mirimanoff RO; Coucke PA
Radiat Res; 1998 Apr; 149(4):338-42. PubMed ID: 9525497
[TBL] [Abstract][Full Text] [Related]
6. in vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer.
Inoue Y; Tanaka K; Hiro J; Yoshiyama S; Toiyama Y; Eguchi T; Miki C; Kusunoki M
Int J Oncol; 2006 Feb; 28(2):479-86. PubMed ID: 16391804
[TBL] [Abstract][Full Text] [Related]
7. Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines.
Stromberg JS; Lee YJ; Armour EP; Martinez AA; Corry PM
Cancer; 1995 May; 75(9):2262-8. PubMed ID: 7712434
[TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells.
Smalley SR; Kimler BF; Evans RG
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):207-11. PubMed ID: 1991680
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro.
Lee JW; Park JK; Lee SH; Kim SY; Cho YB; Kuh HJ
Anticancer Drugs; 2006 Apr; 17(4):377-84. PubMed ID: 16549994
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil-radiation interactions in human colon adenocarcinoma cells.
Buchholz DJ; Lepek KJ; Rich TA; Murray D
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1053-8. PubMed ID: 7607926
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of cytotoxicity and radiosensitization of (E)-2-deoxy-2'-(fluoromethylene) cytidine by pentoxifylline in vitro.
Li YX; Sun LQ; Weber-Johnson K; Paschoud N; Coucke PA
Int J Cancer; 1999 Jan; 80(1):155-60. PubMed ID: 9935246
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M
Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells.
Lim YJ; Rhee JC; Bae YM; Chun WJ
World J Gastroenterol; 2007 Apr; 13(13):1947-52. PubMed ID: 17461495
[TBL] [Abstract][Full Text] [Related]
14. Methylxanthine sensitization of human colon cancer cells to 186Re-labeled monoclonal antibody.
Kinuya S; Yokoyama K; Kudo M; Kasahara Y; Kobayashi K; Motoishi S; Onoma K; Bunko H; Michigishi T; Tonami N
J Nucl Med; 2001 Apr; 42(4):596-600. PubMed ID: 11337548
[TBL] [Abstract][Full Text] [Related]
15. Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.
Zoli W; Ulivi P; Tesei A; Fabbri F; Rosetti M; Maltoni R; Giunchi DC; Ricotti L; Brigliadori G; Vannini I; Amadori D
Breast Cancer Res; 2005; 7(5):R681-9. PubMed ID: 16168113
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.
Xi C; Wang L; Yu J; Ye H; Cao L; Gong Z
Biochem Biophys Res Commun; 2018 Sep; 503(4):2286-2292. PubMed ID: 29959920
[TBL] [Abstract][Full Text] [Related]
17. Triolimus: A Multi-Drug Loaded Polymeric Micelle Containing Paclitaxel, 17-AAG, and Rapamycin as a Novel Radiosensitizer.
Tomoda K; Tam YT; Cho H; Buehler D; Kozak KR; Kwon GS
Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27365266
[TBL] [Abstract][Full Text] [Related]
18. Penetration of paclitaxel and 5-fluorouracil in multicellular layers of human colorectal cancer cells.
Choi MS; Kim SH; Kuh HJ
Oncol Rep; 2011 Mar; 25(3):863-70. PubMed ID: 21225235
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
Yun S; Han YS; Lee JH; Kim S; Lee SH
Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635
[TBL] [Abstract][Full Text] [Related]
20. Albumin Paclitaxel Compared with 5-Penfluorouracil, Lobaplatin, and Albumin Paclitaxel Combined with 5-Penfluorouracil in the Treatment of Human Gastric Cancer Cell AGS Line Autophagy and Apoptosis.
Cheng X; Yang F; Wang Y; Nie W; Mahendra Upadhyay A; Zhang M; Wang Q; Yan Z
Can J Gastroenterol Hepatol; 2022; 2022():6015877. PubMed ID: 35719323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]